Biotechnology - EPIRUS Biopharmaceuticals


Current filters:

EPIRUS Biopharmaceuticals

Popular Filters

Epirus to acquire Zalicus, creating a publicly-traded biosimilars enterprise


Boston-based privately-held Epirus Biopharmaceuticals, focused on the global development and commercialization…

BiosimilarsBiotechnologyEPIRUS BiopharmaceuticalsMergers & AcquisitionsZalicus

Phase III data support biosimilarity of BOW-015 to Remicade


Privately-held US biotech firm EPIRUS Biopharmaceuticals, which is focused on the development and production…

Anti-Arthritics/RheumaticsBiotechnologyEPIRUS BiopharmaceuticalsGenericsinfliximabRegulationRemicadeResearch

Back to top